Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cigna GroupCI · Entity 550 | See Remarks | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cigna Group
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 5,053 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Sale · Disposed 617 · Balance 5,053 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Express Scripts Holding Co.
Report date December 20, 2018 · Filed December 21, 2018
Section 16 reporting ended · disclosed 2018-12-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 1
1 source rowRow 1 · 2018-12-20 · Disposition to issuer · Disposed 31,049 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.17 · Expires 2020-03-06 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-12-20 · Disposition to issuer · Disposed 2,237 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.15 · Expires 2021-03-05 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-12-20 · Disposition to issuer · Disposed 9,387 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.83 · Expires 2025-03-04 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-12-20 · Disposition to issuer · Disposed 9,121 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.08 · Expires 2025-05-06 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-12-20 · Disposition to issuer · Disposed 16,272 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.57 · Expires 2026-03-09 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-12-20 · Disposition to issuer · Disposed 42,643 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.62 · Expires 2027-03-08 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-12-20 · Disposition to issuer · Disposed 51,980 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-12-20 · Disposition to issuer · Disposed 951.6605 · Balance 0 F4: Phantom Stock Unit credited under the Company's Executive Deferred Compensation Plan. F5: Upon distribution, each phantom stock unit would have converted into one share of the Issuer's common stock. F6: Pursuant to the Merger Agreement, upon closing of the Merger, each phantom stock unit was converted into a stock unit relating to the common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F7: Basic Company Credit by the Issuer to Reporting Person's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
F4: Phantom Stock Unit credited under the Company's Executive Deferred Compensation Plan.
F5: Upon distribution, each phantom stock unit would have converted into one share of the Issuer's common stock.
F6: Pursuant to the Merger Agreement, upon closing of the Merger, each phantom stock unit was converted into a stock unit relating to the common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
F7: Basic Company Credit by the Issuer to Reporting Person's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 8, 2026 20:29 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 617 | $284.05 | $175,258.85 |
DisclosureSEC source: 0001641142-26-000003 · wk-form4_1788899344.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,053 F1 · acquired: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 00:18 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 1,719 | $288.91 | $496,636.29 |
DisclosureSEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · nonDerivative · entry 5 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,670 F5 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:18 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,127 | $0.00 Strike: $287.55 | $0.00 |
DisclosureSEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · derivative · entry 6 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,127 Underlying: Common Stock, $.01 Par Value · 4,127 shares Expires 2036-02-27 F6 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2027. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:18 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 517 | $287.55 | $148,663.35 |
DisclosureSEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · nonDerivative · entry 4 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,389 F4 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:18 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 883 | $287.55 | $253,906.65 |
DisclosureSEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · nonDerivative · entry 3 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,906 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:18 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 2,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,789 F2 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2027. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:18 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 2,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,111 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 219 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · derivative · entry 13 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,244 Underlying: Common Stock, $.01 Par Value · 219 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. F4 · derivative.exercise_date: This option was granted on February 23, 2022, and vests in three equal annual installments. The first installment became exercisable on March 1, 2023, and the next two installments become exercisable on March 1, 2024 and March 1, 2025. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 570 | $0.00 Strike: $213.80 | $0.00 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · derivative · entry 12 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,904 Underlying: Common Stock, $.01 Par Value · 570 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. F3 · derivative.exercise_date: This option was granted on February 24, 2021 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2022 and March 1, 2023, and the last installment becomes exercisable on March 1, 2024. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 261 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · derivative · entry 11 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 261 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. F2 · derivative.exercise_date: This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 219 | $227.02 | $49,717.38 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · nonDerivative · entry 7 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 261 | $192.02 | $50,117.22 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · nonDerivative · entry 6 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 570 | $213.80 | $121,866.00 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · nonDerivative · entry 5 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,402 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · derivative · entry 10 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,463 Underlying: Common Stock, $.01 Par Value · 3,402 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. F4 · derivative.exercise_date: This option was granted on February 23, 2022, and vests in three equal annual installments. The first installment became exercisable on March 1, 2023, and the next two installments become exercisable on March 1, 2024 and March 1, 2025. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,236 | $0.00 Strike: $213.80 | $0.00 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · derivative · entry 9 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,474 Underlying: Common Stock, $.01 Par Value · 7,236 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. F3 · derivative.exercise_date: This option was granted on February 24, 2021 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2022 and March 1, 2023, and the last installment becomes exercisable on March 1, 2024. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,519 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · derivative · entry 8 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 261 Underlying: Common Stock, $.01 Par Value · 2,519 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. F2 · derivative.exercise_date: This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 13,157 | $295.21 | $3,884,077.97 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · nonDerivative · entry 4 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,937 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 2,519 | $192.02 | $483,698.38 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · nonDerivative · entry 3 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 3,402 | $227.02 | $772,322.04 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:03 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 7,236 | $213.80 | $1,547,056.80 |
DisclosureSEC source: 0001225208-23-007627 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:43 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 466 | $277.61 | $129,366.26 |
DisclosureSEC source: 0001225208-23-007472 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,937 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 23:23 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 2,982 | $271.67 | $810,119.94 |
DisclosureSEC source: 0001225208-23-003873 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,403 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 22:11 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 454 | $289.00 | $131,206.00 |
DisclosureSEC source: 0001225208-23-003383 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,385 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:11 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 719 | $289.44 | $208,107.36 |
DisclosureSEC source: 0001225208-23-003383 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,839 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 23:01 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 1,772 | $294.06 | $521,074.32 |
DisclosureSEC source: 0001225208-23-002994 · doc4.xml · nonDerivative · entry 4 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,558 F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:01 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 1,683 | $294.27 | $495,256.41 |
DisclosureSEC source: 0001225208-23-002994 · doc4.xml · nonDerivative · entry 3 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,330 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:01 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 228 | $294.27 | $67,093.56 |
DisclosureSEC source: 0001225208-23-002994 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,013 F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:01 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 4,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002994 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:12 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,586 | $0.00 Strike: $294.61 | $0.00 |
DisclosureSEC source: 0001225208-23-002825 · doc4.xml · derivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,586 Underlying: Common Stock, $.01 Par Value · 6,586 shares Expires 2033-02-22 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2024. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:12 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 1,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002825 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Solutions & Corp Devt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,547 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2024. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 01:23 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 902 | $273.98 | $247,129.96 |
DisclosureSEC source: 0001225208-22-009254 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,764 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 23:15 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 466 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-22-008762 · doc4.xml · derivative · entry 5 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,780 Underlying: Common Stock, $.01 Par Value · 466 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. F2 · derivative.exercise_date: This option vests in three equal annual installments. The first installment became exercisable on February 26, 2021, the second installment became exercisable on February 26, 2022, and the last installment becomes exercisable on February 26, 2023. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 23:15 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 466 | $192.02 | $89,481.32 |
DisclosureSEC source: 0001225208-22-008762 · doc4.xml · nonDerivative · entry 3 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 23:15 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,094 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-22-008762 · doc4.xml · derivative · entry 4 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,246 Underlying: Common Stock, $.01 Par Value · 5,094 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. F2 · derivative.exercise_date: This option vests in three equal annual installments. The first installment became exercisable on February 26, 2021, the second installment became exercisable on February 26, 2022, and the last installment becomes exercisable on February 26, 2023. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 23:15 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 5,094 | $275.00 | $1,400,850.00 |
DisclosureSEC source: 0001225208-22-008762 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 23:15 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 5,094 | $192.02 | $978,149.88 |
DisclosureSEC source: 0001225208-22-008762 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:35 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 999 | $250.00 | $249,750.00 |
DisclosureSEC source: 0001225208-22-005737 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 22:29 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 289 | $239.00 | $69,071.00 |
DisclosureSEC source: 0001225208-22-004173 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,199 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:29 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 240 | $236.48 | $56,755.20 |
DisclosureSEC source: 0001225208-22-004173 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,488 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:18 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 268 | $228.70 | $61,291.60 |
DisclosureSEC source: 0001225208-22-003752 · doc4.xml · nonDerivative · entry 4 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,728 F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 01:18 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 415 | $229.64 | $95,300.60 |
DisclosureSEC source: 0001225208-22-003752 · doc4.xml · nonDerivative · entry 3 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,996 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 01:18 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 224 | $229.64 | $51,439.36 |
DisclosureSEC source: 0001225208-22-003752 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,411 F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 01:18 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 1,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003752 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strat, Corp Dev/Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,635 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:49 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,865 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003487 · doc4.xml · derivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,865 Underlying: Common Stock, $.01 Par Value · 10,865 shares Expires 2032-02-23 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:49 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 2,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003487 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,221 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 23:14 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 17 | $0.00 Strike: $176.66 | $0.00 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · derivative · entry 5 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 17 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. F2 · derivative.exercise_date: This option was granted on March 4, 2015. The option vested in three equal annual installments on February 28, 2016, February 28, 2017 and February 28, 2018. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 23:14 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 17 | $176.66 | $3,003.15 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · nonDerivative · entry 3 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 23:14 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 175 | $0.00 Strike: $176.66 | $0.00 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · derivative · entry 4 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Common Stock, $.01 Par Value · 175 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. F2 · derivative.exercise_date: This option was granted on March 4, 2015. The option vested in three equal annual installments on February 28, 2016, February 28, 2017 and February 28, 2018. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 23:14 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 175 | $240.00 | $42,000.00 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,781 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 23:14 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 175 | $176.66 | $30,914.73 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.